These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Alterations of HDL's to piHDL's Proteome in Patients with Chronic Inflammatory Diseases, and HDL-Targeted Therapies. Vyletelová V; Nováková M; Pašková Ľ Pharmaceuticals (Basel); 2022 Oct; 15(10):. PubMed ID: 36297390 [TBL] [Abstract][Full Text] [Related]
4. Looking beyond the Skin: Pathophysiology of Cardiovascular Comorbidity in Psoriasis and the Protective Role of Biologics. Andújar I; Esplugues JV; García-Martínez P Pharmaceuticals (Basel); 2022 Sep; 15(9):. PubMed ID: 36145322 [TBL] [Abstract][Full Text] [Related]
5. Killing Two Birds with One Stone: Potential Therapies Targeting Psoriasis and Atherosclerosis at the Same Time. Merzel Šabović EK; Starbek Zorko M; Janić M Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35743091 [TBL] [Abstract][Full Text] [Related]
6. Psoriasis and Cardiometabolic Diseases: The Impact of Inflammation on Vascular Health. Teklu M; Parel PM; Mehta NN Psoriasis (Auckl); 2021; 11():99-108. PubMed ID: 34322373 [TBL] [Abstract][Full Text] [Related]
8. High-Density Lipoprotein (HDL) in Allergy and Skin Diseases: Focus on Immunomodulating Functions. Trakaki A; Marsche G Biomedicines; 2020 Dec; 8(12):. PubMed ID: 33271807 [TBL] [Abstract][Full Text] [Related]
9. Oxidized Lipids and Lipoprotein Dysfunction in Psoriasis. Sorokin AV; Remaley AT; Mehta NN J Psoriasis Psoriatic Arthritis; 2020 Oct; 5(4):139-146. PubMed ID: 33163854 [TBL] [Abstract][Full Text] [Related]
10. Establishment of Mouse Models of Psoriasis with Blood Stasis Syndrome Complicated with Glucose and Lipid Metabolism Disorders. Luo Y; Ru Y; Zhao H; Liu L; Hong S; Sun X; Kuai L; Lu Y; Xing M; Chen X; Song J; Luo Y; Fei X; Zhou Y; Li H; Li B; Li X Evid Based Complement Alternat Med; 2019; 2019():6419509. PubMed ID: 31781274 [TBL] [Abstract][Full Text] [Related]
11. Atherogenesis in Psoriasis: Evaluation of the Serum Activities of Non-high-density Lipoprotein Cholesterol and Other Lipids Among Newly Diagnosed Psoriasis Patients. Thungaturthi S; Vadakedath S; Pavuluri P; Rani J; Gundu R; Bheem J; Kandi V Cureus; 2019 Mar; 11(3):e4203. PubMed ID: 31114722 [TBL] [Abstract][Full Text] [Related]
13. Total cholesterol and LDL levels decrease before rheumatoid arthritis. Myasoedova E; Crowson CS; Kremers HM; Fitz-Gibbon PD; Therneau TM; Gabriel SE Ann Rheum Dis; 2010 Jul; 69(7):1310-4. PubMed ID: 19854708 [TBL] [Abstract][Full Text] [Related]
14. Decreased Serum Lipid Levels and Ratios Correlate with Low Prevalence of Coronary Heart Disease in Patients with Parkinson's Disease. Bao M; Hu R; Chen Y; Wang N; Xue H; He J; Jin J; Kong W; Ke G; Xue Q Clin Lab; 2018 Sep; 64(9):1413-1419. PubMed ID: 30274018 [TBL] [Abstract][Full Text] [Related]
15. Beyond low-density lipoprotein cholesterol: respective contributions of non-high-density lipoprotein cholesterol levels, triglycerides, and the total cholesterol/high-density lipoprotein cholesterol ratio to coronary heart disease risk in apparently healthy men and women. Arsenault BJ; Rana JS; Stroes ES; Després JP; Shah PK; Kastelein JJ; Wareham NJ; Boekholdt SM; Khaw KT J Am Coll Cardiol; 2009 Dec; 55(1):35-41. PubMed ID: 20117361 [TBL] [Abstract][Full Text] [Related]
16. Lipid profile abnormalities seen in T2DM patients in primary healthcare in Turkey: a cross-sectional study. Ozder A Lipids Health Dis; 2014 Dec; 13():183. PubMed ID: 25481115 [TBL] [Abstract][Full Text] [Related]
17. Targeting low HDL-cholesterol to decrease residual cardiovascular risk in the managed care setting. Cziraky MJ; Watson KE; Talbert RL J Manag Care Pharm; 2008 Oct; 14(8 Suppl):S3-28; quiz S30-1. PubMed ID: 19891279 [TBL] [Abstract][Full Text] [Related]
18. Trends in lipid profiles in patients with psoriasis: a population-based analysis. Akkara Veetil BM; Matteson EL; Maradit-Kremers H; McEvoy MT; Crowson CS BMC Dermatol; 2012 Oct; 12():20. PubMed ID: 23110323 [TBL] [Abstract][Full Text] [Related]